Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Fragile underlying quality score of 13/100; weak margins or elevated debt leverage warrant caution.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Verdict: Highly distressed profile flashing severe fundamental warning signs.
Wall Street is highly bullish, projecting significant upside alongside robust expected earnings growth. The company currently retains all capital for reinvestment and growth rather than returning it to shareholders.
GEMI struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company maintains stable top-line performance paired with stable bottom-line earnings. However, profitability remains a major concern with severely compressed operating margins (-281.4%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $39.4M | +2.8% | — | — | — | |
| EBITDA | -$97.6M | — | — | — | — | |
| Net Income | -$109.0M | -267.6% | — | — | — | |
| EPS (Diluted) | $-0.93 | -404.1% | — | — | — | |
| Free Cash Flow | -$54.6M | -96.5% | — | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | -1.1% | 21.6% | 21.6% | 21.6% |
| Operating Margin | -281.4% | -264.3% | -264.3% | -264.3% |
| Net Margin | -362.9% | -278.7% | -278.7% | -278.7% |
| FCF Margin | -171.3% | -151.2% | -151.2% | -151.2% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $-0.90 | $-0.93 | -3.3% | ||
| Q1'26 | $-1.06 | $-1.22 | -15.1% | ||
| Q4'25 | $-0.82 | $-1.81 | -120.7% |
Total return is -85.3% (1Y), lagging the benchmark by -110.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -54.5% | -63.8% | — |
| 1Y | -85.3% | -110.3% | — |
| 3YCAGR | -47.2% | -66.5% | — |
| 5YCAGR | -31.8% | -44.1% | — |
| 10YCAGR | -17.4% | -31.0% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Gemini Space Station, Inc. Class A Common Stock (GEMI) valuation, health, and returns.
Based on peer relative multiples, Gemini Space Station, Inc. Class A Common Stock appears Limited: Cheap versus peers compared to industry peers.
Gemini Space Station, Inc. Class A Common Stock has multiple valuation anchors: Peer Relative Fair Value: $14.51 | Wall Street Analyst Target: $9.64 (implying +104.7% upside). A convergence of these signals offers higher conviction.
Gemini Space Station, Inc. Class A Common Stock displays poor financial health with a composite quality score of 13/100, supported by a Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of -37.0%.
Gemini Space Station, Inc. Class A Common Stock does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Gemini Space Station, Inc. Class A Common Stock's current growth trajectory is Stable. The company achieved +2.8% 1Y revenue growth and -404.1% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Buy based on 9 analysts. The consensus price target represents a +104.7% change from current levels.
Investment risks for Gemini Space Station, Inc. Class A Common Stock include: -87.6% 1-year max drawdown, high beta (3.33x market volatility). Volatility risk is characterized by a beta of 3.33x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.